chrisvoncsefalvay/vaers-outcomes huggingface dataset:
diarrhea; numbness on my finger; My finger is still a little bit, it's hard to move; stomach is not settled; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9262), via an unspecified route of administration on 02Feb2021 as a single dose for COVID-19 immunization. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1283), via an unspecified route of administration on an unknown date. The patient's medical history was not reported. For concomitant medications patient stated, "Yes, I just take medication that is not really important for that. No lab work but she stated, I think I did. I checked my Vitamin D, it wasn't in two weeks may be in the month of Feb, I can't recall but it's not too long ago within the but I can't pin point the date. The patient also stated that three days after she received the second dose on 03Feb, she developed diarrhoea which has been going on for 7 days. The patient stated that her stomach was not settled and she was laying in the bed. The patient also felt numbness in her finger. She has also noticed her pinky was getting stiff. The patient stated that her finger was still a little bit hard to move but the diarrhoea part was subsiding. The outcome of the events was resolving for diarrhoea, not resolved for numbness of finger and unknown for "my finger is still a little bit, it's hard to move" and "Her stomach is not settled". On 08Mar2021, Information received from a same contactable consumer in response to Non-HCP letter sent via email included requested for additional information since can't open AER. On 12Mar2021, different start date for second dose and lot numbers were obtained as (LOT#2: 02Feb I think it's EL9262, LOT#1: EL1283).   Follow-up attempts completed. No further information expected.
My husband and I booked our 1st vaccine together, when we got there I received mine first and sat out for the (15)min waiting period. Once my husband received his, he walked to me and asked me if I was ok because I looked extremely pale. I told my husband I felt extremely dizzy and not well. The Pharmacist manager came to us and offered me water because how ill I looked. Next thing you know I tell my husband I'm really dizzy and I fainted. While I fainted my husband told me that my eyes rolled back, my throat locked on me, I wasn't breathing for at least 15-20 seconds....not until they moved my body to the side that's when I started vomiting and started waking up...Immediately the fire department and paramedics along with the police department are by me taking my vitals but I kept vomiting. I was so scared to go to the hospital so they had me sign a waiver to release me in my husbands care. Once we got home, I kept vomiting for 3 hours. I literally thought I was going to die. I've never in my life have been scared of death until that day.
This is a spontaneous report from a contactable other hcp. A 62-years-old female patient (Non Pregnant; Consumer) reported for herself that she received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection; Lot Number: EP 6995), intramuscular, administered in Arm Left on 20Mar2021 13:30 (the Age of 62-Years-Old) as DOSE 1, SINGLE for covid-19 immunization. Medical history included Pre-diabetes/glucose intolerance, peripheral neuropathy, PACs, PVCs, osteopenia from an unknown date and unknown if ongoing. Concomitant medication(s) included metformin (METFORMIN) ,sitagliptin phosphate (JANUVIA), atorvastatin (ATORVASTATIN), valaciclovir (VALACICLOVIR), famotidine (FAMOTIDINE), calcium citrate (CALCIUM CITRATE)and vitamin d3 (VITAMIN D3) taken for an unspecified indication, start and stop date were not reported. The Patient did not take any other vaccine in four weeks On 21Mar2021, at 12:00 pm the patient experienced diarrhea within 24 hours of first dose. Intermittent occurrence until dose 2. Non-responsive to antibiotic therapy, diet modification. No improvement. Awaiting endoscopic exam. The patient took Antibiotic therapy, symptomatic treatment, FODMAP diet for treatment of the events. The outcome for Diarrhoea was not recovered. Follow-up attempts are completed. No further information is expected. Sender's Comments: Linked Report(s) : US-PFIZER INC-2021654173 same patient/reporter/product, different event,
she had taken the tablets so it can be helpful for her right shoulder; This is a spontaneous report from a contactable consumer (patient) from a Pfizer Sponsored Program. A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 24Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient called to advise that she had taken two (2) tablets of Ibuprofen the night after she got her first dose of the covid-19 vaccine yesterday (24Mar2021) around 2 o'clock in the afternoon. According to patient, she had taken the tablets so it can be helpful for her right shoulder since that morning she had an MRI, only then she realized why she had taken the tablets when she knew that she was not supposed to be taking Ibuprofen during the vaccine. Outcome of the event was unknown.  Information on the lot/batch number has been requested.
MMR and Varicella #2 given 1 week after the 1 dose Pt. c/o rash on skin and fever of 100.3
Negative, Non-Immune (Hep B Surface Antibody Titer); Negative, Non-Immune (Hep B Surface Antibody Titer); Initial Report Received on 27-Dec-2022, 28-Dec-2022 and 29-Dec-2022 (confirmed immunological failure)  This is a spontaneous report received from an Advanced Nurse Practitioner (ANP) who reported that a 53-year-old male who received HEPLISAV-B for Hepatitis B immunization had a "negative, non-immune" titer after having received 2 doses of HEPLISAV-B.  There were no medications or additional medical history provided.   On 27-Sep-2022, dose 1 of HEPLISAV-B (Lot # 938793, expiration date 07-Oct-2023, NDC not provided), was administered intramuscularly in the left deltoid by work.  On 31-Oct-2022, dose 2 of HEPLISAV-B (Lot # 938794, expiration date 09-Oct-2023, NDC not provided), was administered intramuscularly in the left deltoid by work.  On 20-Dec-2022, 85 days after dose 1 and 51 days after dose 2 of HEPLISAV-B, a Hepatitis B surface antibody titer was drawn and the results were reported as "non-reactive."   No additional information was provided.   Company Comment: The company assessed the event as non-serious and confirmed immunological  failure based on the dosing interval, time to serological marker testing and antibody titer.; Sender's Comments: The company assessed the event as non-serious and confirmed immunological  failure based on the dosing interval, time to serological marker testing and antibody titer.
shaking chill, fever to 103, pain, tederness, and swelling at site of injection
Pt was here for 8:30 am nurse visit for imms - pt did not eat breakfast prior to appt - pt rec'd 4 shots and approx 3-4 mins after injections, pt passed out. Ammonic inhalant used & pt came to right away.
Felt like he had COVID-19 virus again; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Felt like he had COVID-19 virus again) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (was hospitalized) in October 2020.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced COVID-19 (Felt like he had COVID-19 virus again). At the time of the report, COVID-19 (Felt like he had COVID-19 virus again) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient reported on the same evening (as his vaccine) he just felt sick, but this morning he felt better.  No concomitant medication use was provided by the reporter.  Treatment of events was not reported.
woke up gasping for breath, difficulty breathing, chest constriction with pain, heart pressure, pulse pressure in shoulders, neck and top of head treated with Cardio Care and Aconitum Napellus 30 C every 1/2 hr to 1 hr depending on symptom expression and walking and staying up right caused improvement of symptoms.  Laying down and lack of movement cause symptom worsening, difficulty in breathing and increasing chest & heart pressure
Local area of redness around injection site R deltoid 4 x 4 1/2cm of redness, warm to touch.
Mom called on 5/27/2010 stating that child was noted to having jerking movements that was accompanied by staring. These episodes occurred about 7 times approx 10 seconds apart then stopped then again at 11:00 PM X 4.
Information has been reported in a study. The report includes VAERS reports following PNEUMOVAX 23 or Pneumococcal polysaccharide vaccine (PPSV23) brand unknown after 2002. The report includes reports information from 01-JAN-1990 to 13-JAN-2014. This spontaneous report as received from an other health professional refers to 4 patients. The median age of the patients was 69 years old; range being 23 to 98 years. Between 01-JAN-1990 and 31-DEC-2013 patients were vaccinated with PNEUMOVAX 23. On an unknown date the patients experienced death. The outcome of death was reported as fatal. The cause of death was reported as 'undetermined'. The death of the patients was confirmed with medical records, autopsy reports and/or death certificates. The report has been split into cases according to cause of death. This case is linked to same reporter linked cases # 1406USA003857 (respiratory disorder), 1406USA003863 (Unknown), 1406USA003859 (other non infectious disorder), 1406USA003860 (gastrointestinal), 1406USA003861 (Neurological), 1406USA003862 (Undetermined) and 1406USA003351 (Cardiovascular). Additional information has been requested.
Woke up in the night due to fever. When I woke in morning I had headache and nausea. Couldn?t sleep on right arm. Symptoms lasted until 8:00 pm the following night. My arm is still puffy and red and sore. I have a rash on injection site. Also bled when I got the vaccine which hasn?t happened before.
Blurry vision in right eye-several days later developed pain and sensitivity on right side of head, behind eye, drooping swollen right eyelid, pain in ear and jaw.  Eye doctor sent patient to emergency room-after blood tests, CT scan, contrast MRI, Doppler ultra sound on carotid artery, patient was diagnosed with temporal arteritis--prescribed 80 mg prednisone daily. Patient is still on reduced dose prednisone and is feeling better.
"after my 2nd shot i got a swollen area, with some redness which according the email was normal but what concerned me was alot of itching to the site which is still there along with the redness and swelling."
-patient requested water then he started feeling dizzy and almost passing out a few minutes after getting the vaccine. Ems  came and took patient to hospital for evaluation
Vaccine given 2/2/01. Pt developed acne-like rash on face and generalized itchy, tingly skin on 2/9/01. Pt was instructed to use Benadryl and call office if not improved.
Patient said he was feeling lightheaded and shaky. He was asked if he had trouble breathing and he said yes. One dose of Epipen was given and 911 was called.
Systemic: Chills-Severe, Systemic: Headache-Severe, Systemic: Hypertension-Severe, Additional Details: AFTER 15 MINUTES PT GOT UP AND STARTED NOT FELLING GOOD. BLOOD PRESSURE 215/182.. TAKEN AGAIN 205/180.. DAUGHTER CALLED AMBULANCE. SHE DECIDED NOT TO GO AFTER HER DAUGHTER BROUGHT HER HCTZ. WILL CALL MONDAY TO FOLLOW UP.
Dry cough that started within the two weeks to full effectiveness period after the second shot progressed to bronchitis within a week. I don't think I've ever had bronchitis-only head colds/infections.
1/3/2021  VACCINATION. BY 6PM, HA. CHILLS AND SHAKING CAME OVER NIGHT. TEMP O F 100.03, TOPPED OUT AT 100.6. 1/4/2021 ABDOMINAL CRAMPING/DIARRHEA. CONVERSED WITH MEDICAL STAFF AND DETERMINED THAT COVID ANTIBODIES HAD A DUAL RESPONSE TO COVID AND LEARNING IT.  36 HOUR AFTER, FEEL BACK TO NORMAL.  *FEEL THAT THIS WAS NOT A DIRECT ADVERSE REACTION TO THE VACCINE, RATHER IMMUNE RESPONSE TO RECENT BOUT WITH COVID.
L groin itching, raised rash. Spread to entire Abd, chest, buttock, lower back and both arms, Left ear ache and sore throat, swollen neck glands.
Week 1: Fever of 103.5+ for two nights; myalgia; chills; vomiting; severe fatigue; red rash over approx. 80 percent of body; severe flu-like illness  Week 1 Treatment: Antihistamines, NSAIDs, Analgesics, Five day burst corticosteroid therapy.  Week 4-9: Intermittent loss of feeling left arm (pins and needles) accompanied with tightness in left chest that persisted for  about one month;  Week 4-9 Treatment: N/A
Customer reports patient experienced no systemic reactions. No additional adverse event reported; Customer reports PROQUAD was inadvertently mixed with MENACTRA as a diluent and administered to a patient.; Customer reports PROQUAD was inadvertently mixed with MENACTRA as a diluent and administered to a patient.; This spontaneous report has been received from a registered nurse concerning a 11-year-old patient. The patient's relevant medical history, drug reactions/allergies, concurrent conditions and concomitant therapies were not reported.  On 26-FEB-2021, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (rHA (recombinant human albumin)) (1 dose, lot # T027113, expiration date: 07-FEB-2022. Strength, dose, route of administration, anatomical location, and frequency, were not provided) for prophylaxis, which was inadvertently mixed with meningococcal ACYW conj vaccine (dip toxoid) (MENACTRA) (1 dose, lot # U6787AA, expiration date: 08-NOV-2021. Strength, dose, route of administration, anatomical location, indication and frequency, were not provided) as a diluent (wrong product administered) (product preparation error). During this visit, the patient was also given HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (1 dose, lot # T007035, expiration date 01-MAY-2022. Strength, dose, route of administration, anatomical location, and frequency, were not provided), which was administered appropriately for prophylaxis according to prescribing information (unspecified information).   According to the reporter, the patient did not experience any systemic reactions and no additional adverse event was reported.
Severe headache; flu-like symptoms; feeling terrible; This is a spontaneous report from a contactable nurse via Pfizer sales representative. A 20-year-old male patient received meningococcal group b rlp2086 (TRUMENBA) at single dose, and diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (TDAP), at unspecified dose; both via unspecified routes of administration on unspecified dates for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced severe headache and flu-like symptoms and was feeling terrible for 30 hours after receiving meningococcal group b rlp2086. It was reported that meningococcal group b rlp2086  was given with Tdapmin separate arms. Outcome of the events was recovered on an unspecified date.   No follow-up attempts are possible. No further information is expected.
Received varivax 02-27-97. Diagnosed with Varicella 4-30-04.
Headache, Fever, Diarrhea, NauseaVomiting, difficulties with temperature regulation: fevers and  chills; fatigue Narrative:   Other Relevant History:
Three weeks after my 2nd injection, I had a heavy period starting on March 11, 2021.  I had just had an annual exam on March 8, 2021, and I discussed with my doctor that I was officially going into menopause.   I had not had a period in a year, almost to the day - March 17, 2020.
tingling at the bottom of two toes on my left foot; stinging in my face; itchiness in my face; rash; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling at the bottom of two toes on my left foot), PAIN (stinging in my face), PRURITUS (itchiness in my face) and RASH (rash) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 011A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient experienced PARAESTHESIA (tingling at the bottom of two toes on my left foot), PAIN (stinging in my face), PRURITUS (itchiness in my face) and RASH (rash). The patient was treated with PREDNISONE at a dose of UNK dosage form. At the time of the report, PARAESTHESIA (tingling at the bottom of two toes on my left foot), PAIN (stinging in my face), PRURITUS (itchiness in my face) and RASH (rash) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Other treatment medication included hydrocortisone cream Action taken with mRNA-1273 in response to the event was not applicable
fast heart beats; confusion; difficulty breathing; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (fast heart beats), CONFUSIONAL STATE (confusion), DYSPNOEA (difficulty breathing) and DIZZINESS (dizziness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced TACHYCARDIA (fast heart beats), CONFUSIONAL STATE (confusion), DYSPNOEA (difficulty breathing) and DIZZINESS (dizziness). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. On 20-Jan-2021, TACHYCARDIA (fast heart beats), CONFUSIONAL STATE (confusion), DYSPNOEA (difficulty breathing) and DIZZINESS (dizziness) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment information provided
Additional information received from the physician 07/03/02, included recovery status of thepatient and a  further description of the adverse  events. A nurse reported that she inadvertently received a subcutaneous injection of Flu Shield instead of PPD. On 5/3/02, she developed a tender wheal at the injection site. the patient recovered approximately 72 hours later. MANUFACTURER'S Comment: Flu shield (2001-2002 Formula was maladministrered to this patient, as well as several other patient. See related report: HQ2190007MAY2002.
2 hours later, had a slight headache; Right arm that I took the vaccine is really hurting; Feeling like heavy; I am just really sore, my whole body; This is a spontaneous report from a contactable consumer reporting for self.  A patient of unspecified age and gender received bnt162b2 (BNT162B2) vaccine , via an unspecified route of administration in the right arm  on 23Dec2020 at single dose for Covid-19 immunisation .  The patient medical history and  concomitant medications were not reported.  The patient experienced 2 hours after receiving the vaccine   a slight headache and took Tylenol (taken as treatment) the patient just felt like heavy. The right arm  where the vaccine  was given was really hurting. the patient was just really sore, the  whole body. The outcome of the events was unknown.  Information on the lot/batch number has been requested
Information has been received from a pharmacist, via Pfizer (Source document # 2016428486), concerning a 71 years old patient of unknown gender. The patient's pertinent medical history and concurrent conditions were not informed. On unspecified date in October of 2015, the patient was vaccinated with PREVNAR 13 (lot #, expiration date, concentration, dosage and therapy route were not provided), and a couple of weeks later the patient was inadvertently given the PNEUMOVAX 23 (lot #, expiration date, concentration, dosage and therapy route were not provided), instead of waiting for a year. Concomitant therapies were not informed. The pharmacist asked if the vaccination need to be repeated. Additionally mentioned a possible adverse event. The outcome of possible adverse event was unknown at the time of the report. The causal relationship between possible adverse event and PNEUMOVAX 23 was not reported. Additional information has been requested.
I was feeling very fatigue, scratchy throat and as day went on got more tired. My temperature was 99.9 degrees, said I had a sinus infection. I had tele health visit by 6PM I was in the urgent care because my temperature was high. My buttocks and thigh were also hurting. I saw a nurse practitioner who tested me on 02/07/2023 for COVID-19 and it was negative and also took a flu test and it was Influenza type A. I felt worse by the next day and slept the next day all day long. I also had nasal congestion. My symptoms lasted 7-10 days until I started to feel better.
Red knot on vaccine site (4cm diameter); Warm to touch; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via unspecified route of administration in left arm on 10Mar2021 at 16:45 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient possibly allergic to penicillin and onion food intolerance. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. It was reported that the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 19Mar2021 at 14:30, the patient experienced red knot on vaccine site (4 cm diameter), warm to touch. The patient did not receive treatment for the events. The clinical outcome of red knot on vaccine site (4cm diameter), warm to touch were not recovered.  No follow-up attempts are needed. No further information is expected
Friday, tired and chills. Sat. woke up about 7am, went to get up room was turning the next thing I knew woke up at 9am.  Weak, chills, ache all over , nausea, dizzy, AFIB is not normal. Sunday,   was room turning not as bad but happening often, weak and dizzy, nausea, .Feel like I am in a fog. AFIB is not normal. Still the same, with the first vaccine it was 10 days before I felt normal.  If things do not get better will seek medical attention
After the vaccine, my lymph nodes grew, low temp fever and body aches. I only took Tylenol. In May, I was diagnosed with shingles. This month (June) I was diagnosed with kidney stones and fatty liver and enlarged liver. Also, something growing in my uterus, not a tumor, but something growing under the muscle.
Pain, weakness, fatigue, abnormal mentation, tongue throbbing, cough, hoarse voice